<DOC>
	<DOCNO>NCT02396680</DOCNO>
	<brief_summary>The purpose study determine efficacy Ragweed-SPIRE 12 month initial dose .</brief_summary>
	<brief_title>Ragweed-SPIRE Follow-On Study</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<criteria>Â° Previously randomise complete least 6 8 treatment visit Study TR006 Subject Investigator inform treatment receive Study TR006 Subjects significant allergy animal dander Any allergen immunotherapy since complete Study TR006 use prohibit therapy History recurrent acute sinusitis chronic sinusitis Received treatment investigational drug within 4 week Screening Unable understand study requirement unable communicate clearly Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Ragweed Allergy</keyword>
	<keyword>Rhinoconjunctivitis</keyword>
	<keyword>Immunotherapy</keyword>
	<keyword>Ragweed-SPIRE</keyword>
</DOC>